📋 PLUS THERAPEUTICS, INC. (PSTV) - Financial Results
Filing Date: 2026-03-12
Accepted: 2026-03-12 16:21:10
Event Type: Financial Results
Event Details:
PLUS THERAPEUTICS, INC. (PSTV) Reports the reporting period Financial Results
PLUS THERAPEUTICS, INC. (PSTV) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 4768
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 8758
up and REYOBIQ pivotal trial readiness; we also are looking aggressively for ways to over achieve where possible.” Q4 2025 AND RECENT HIGHLIGHTS Corporate
Completed an upsized public offering generating $15 million in gross proceeds, extending the Company’s projected cash runway and supporting CNSide commercialization and advancement of two ongoing Phase 2 clinical programs REYOBIQ™ Development
Secured American Medical Association Category III CPT reimbursement code for convection
📋 PLUS THERAPEUTICS, INC. (PSTV) - Financial Results
Filing Date: 2026-03-12
Accepted: 2026-03-12 16:21:10
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: